Publication:
Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations

Thumbnail Image

Date

2013

Journal Title

Journal ISSN

Volume Title

Publisher

Public Library of Science
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Burke, L. S., P. L. Hyland, R. M. Pfeiffer, J. Prescott, W. Wheeler, L. Mirabello, S. A. Savage, et al. 2013. “Telomere Length and the Risk of Cutaneous Malignant Melanoma in Melanoma-Prone Families with and without CDKN2A Mutations.” PLoS ONE 8 (8): e71121. doi:10.1371/journal.pone.0071121. http://dx.doi.org/10.1371/journal.pone.0071121.

Research Data

Abstract

Introduction: Recent evidence suggests a link between constitutional telomere length (TL) and cancer risk. Previous studies have suggested that longer telomeres were associated with an increased risk of melanoma and larger size and number of nevi. The goal of this study was to examine whether TL modified the risk of melanoma in melanoma-prone families with and without CDKN2A germline mutations. Materials and Methods We measured TL in blood DNA in 119 cutaneous malignant melanoma (CMM) cases and 208 unaffected individuals. We also genotyped 13 tagging SNPs in TERT. Results: We found that longer telomeres were associated with an increased risk of CMM (adjusted OR = 2.81, 95% CI = 1.02–7.72, P = 0.04). The association of longer TL with CMM risk was seen in CDKN2A- cases but not in CDKN2A+ cases. Among CMM cases, the presence of solar injury was associated with shorter telomeres (P = 0.002). One SNP in TERT, rs2735940, was significantly associated with TL (P = 0.002) after Bonferroni correction. Discussion Our findings suggest that TL regulation could be variable by CDKN2A mutation status, sun exposure, and pigmentation phenotype. Therefore, TL measurement alone may not be a good marker for predicting CMM risk.

Description

Keywords

Biology, Genetics, Cancer Genetics, Epigenetics, Genetics of Disease, Genomics, Chromosome Biology, Telomeres, Medicine, Dermatology, Skin Neoplasms, Malignant Skin Neoplasms, Melanomas, Epidemiology, Cancer Epidemiology, Genetic Epidemiology, Oncology, Cancer Risk Factors, Cancers and Neoplasms

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories